Palisade Capital Management LLC Gilead Sciences, Inc. Transaction History

Palisade Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $199,424 - $286,304	3,200 New	3,200 $274,000
Q1 2022 May 09, 2022	SELL	$57.92 - $72.58 $185,344 - $232,256	-3,200 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $19,464 - $22,092	-300 Reduced 8.57%	3,200 $232,000
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $8,497 - $9,682	-150 Reduced 4.11%	3,500 $204,000
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $277,575 - $362,215	-4,585 Reduced 55.68%	3,650 $228,000
Q1 2018 May 09, 2018	SELL	$72.84 - $88.8 $72,840 - $88,800	-1,000 Reduced 10.83%	8,235 $621,000
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $71,150 - $83,520	1,000 Added 12.14%	9,235 $662,000
Q3 2017 Oct 31, 2017	BUY	$72.11 - $85.47 $593,825 - $703,845	8,235	8,235 $667,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Palisade Capital Management LLC with notifications on news.